GlassScriptPhysician profile
Anna Sullivan Overby
NPI 1285073395
$3,299.58
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $328 · 2021: $912 · 2022: $871 · 2023: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $610.09 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $418.75 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $374.40 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.92 | 2019-2023 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $279.58 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $254.26 | 2019-2023 | Verquvo, Dificid, Zerbaxa |
| E.R. Squibb & Sons, L.L.C. | $200.02 | 2019-2022 | |
| Gilead Sciences, INC. | $169.87 | 2021-2023 | Veklury |
| Otsuka America Pharmaceutical, INC. | $119.19 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.44 | 2020-2023 | Xifaxan |
| Paratek Pharmaceuticals, INC. | $96.09 | 2022-2023 | Nuzyra |
| Melinta Therapeutics, LLC | $70.27 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $49.83 | 2019-2023 | Ultomiris |
| Boston Scientific Corporation | $40.00 | 2021-2022 | |
| Cvrx, INC. | $29.72 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $28.37 | 2019 | |
| Novo Nordisk INC | $25.38 | 2019 | |
| Lundbeck LLC | $23.04 | 2019 | |
| Cmp Pharma, INC. | $22.15 | 2021 | |
| Philips North America LLC | $21.02 | 2023 | |
| Electromed, INC. | $14.59 | 2023 | Smartvest |
| Shire North American Group INC | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Overby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.